Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio
Go back to Incyte Completes Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 126.39 +1.99 (1.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.40 | 52 Week High | $118.49 | |||
| Open | $125.66 | 52 Week Low | $55.00 | |||
| Day High | $127.02 | P/E | N/A | |||
| Day Low | $123.57 | EPS | $-0.56 | |||
| Volume | 225,802 | |||||
